As noted above, mHSPCs are often high-grade tumors with several genomic mutations occurring following the initial PC diagnosis, thus it is possible that the AST/ALT ratio was not significantly increased at the time of mCRPC diagnosis, with the tumor volume reduction effect of ADT another important factor. The gene discussed is GOT1; the disease is neoplasm.